Organic anion-transporting polypeptides

Current Topics in Membranes

Volumn 73, Issue , 2014, Pages 205-232

  Stieger, Bruno ^a   Hagenbuch, Bruno ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Drug; OATP; Organic anion; Transport

Indexed keywords

BIOLOGICAL PRODUCT; ORGANIC ANION TRANSPORTER;

ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PROTEIN PROCESSING; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL PRODUCTS; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION; HUMANS; ORGANIC ANION TRANSPORTERS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 84898604570     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800223-0.00005-0     Document Type: Chapter

References (149)

1. Abe T., Unno M., Onogawa T., Tokui T., Kondo T.N., Nakagomi R., et al. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 2001, 120(7):1689-1699.
2. Bailey D.G., Dresser G.K., Leake B.F., Kim R.B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clinical Pharmacology and Therapeutics 2007, 81(4):495-502.
3. Bossuyt X., Muller M., Hagenbuch B., Meier P.J. Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. The Journal of Pharmacology and Experimental Therapeutics 1996, 276(3):891-896.
4. Bossuyt X., Muller M., Meier P.J. Multispecific amphipathic substrate transport by an organic anion transporter of human liver. Journal of Hepatology 1996, 25(5):733-738.
5. Boyer J.L., Graf J., Meier P.J. Hepatic transport systems regulating pHi, cell volume, and bile secretion. Annual Review of Physiology 1992, 54:415-438.
6. Briz O., Romero M.R., Martinez-Becerra P., Macias R.I., Perez M.J., Jimenez F., et al. OATP8/1B3-mediated cotransport of bile acids and glutathione: An export pathway for organic anions from hepatocytes?. The Journal of Biological Chemistry 2006, 281(41):30326-30335.
7. Briz O., Serrano M.A., MacIas R.I., Gonzalez-Gallego J., Marin J.J. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. The Biochemical Journal 2003, 371(Pt. 3):897-905.
8. Brouwer K.L., Keppler D., Hoffmaster K.A., Bow D.A., Cheng Y., Lai Y., et al. In vitro methods to support transporter evaluation in drug discovery and development. Clinical Pharmacology and Therapeutics 2013, 94(1):95-112.
9. Buch S., Schafmayer C., Volzke H., Seeger M., Miquel J.F., Sookoian S.C., et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology 2010, 139(6):1942-1951.
10. Chu X., Korzekwa K., Elsby R., Fenner K., Galetin A., Lai Y., et al. Intracellular drug concentrations and transporters: Measurement, modeling, and implications for the liver. Clinical Pharmacology and Therapeutics 2013, 94(1):126-141.
11. Clarenburg R., Kao C.C. Shared and separate pathways for biliary excretion of bilirubin and BSP in rats. The American Journal of Physiology 1973, 225(1):192-200.
12. Clarke J.D., Cherrington N.J. Genetics or environment in drug transport: The case of organic anion transporting polypeptides and adverse drug reactions. Expert Opinion on Drug Metabolism & Toxicology 2012, 8(3):349-360.
13. Cui Y., Konig J., Leier I., Buchholz U., Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. The Journal of Biological Chemistry 2001, 276(13):9626-9630.
14. Cutler M.J., Choo E.F. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Current Drug Metabolism 2011, 12(8):793-807.
15. Daniel H., Fett C., Kratz A. Demonstration and modification of intervillous pH profiles in rat small intestine in vitro. The American Journal of Physiology 1989, 257(4 Pt. 1):G489-G495.
16. Degorter M.K., Ho R.H., Leake B.F., Tirona R.G., Kim R.B. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. Molecular Pharmaceutics 2012, 9(4):986-995.
17. Dolton M.J., Roufogalis B.D., McLachlan A.J. Fruit juices as perpetrators of drug interactions: The role of organic anion-transporting polypeptides. Clinical Pharmacology and Therapeutics 2012, 92(5):622-630.
18. Dresser G.K., Bailey D.G., Leake B.F., Schwarz U.I., Dawson P.A., Freeman D.J., et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical Pharmacology and Therapeutics 2002, 71(1):11-20.
19. Eloranta J.J., Hiller C., Juttner M., Kullak-Ublick G.A. The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor. Molecular Pharmacology 2012, 82(1):37-46.
20. Eloranta J.J., Kullak-Ublick G.A. The role of FXR in disorders of bile acid homeostasis. Physiology (Bethesda) 2008, 23:286-295.
21. Fenner K.S., Jones H.M., Ullah M., Kempshall S., Dickins M., Lai Y., et al. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: From obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 2012, 42(1):28-45.
22. Ferenci P., Scherzer T.M., Kerschner H., Rutter K., Beinhardt S., Hofer H., et al. Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. Gastroenterology 2008, 135(5):1561-1567.
23. Frimmer M. Organotropism by carrier-mediated transport. Trends in Pharmacological Sciences 1982, 3:395-397.
24. Frimmer M., Ziegler K. The transport of bile acids in liver cells. Biochimica et Biophysica Acta 1988, 947(1):75-99.
25. Fuchikami H., Satoh H., Tsujimoto M., Ohdo S., Ohtani H., Sawada Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metabolism and Disposition 2006, 34(4):577-582.
26. Geier A., Wagner M., Dietrich C.G., Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochimica et Biophysica Acta 2007, 1773(3):283-308.
27. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacological Reviews 2006, 58(4):685-704.
28. Giacomini K.M., Huang S.M., Tweedie D.J., Benet L.Z., Brouwer K.L., Chu X., et al. Membrane transporters in drug development. Nature Reviews Drug Discovery 2010, 9(3):215-236.
29. Glaeser H., Bailey D.G., Dresser G.K., Gregor J.C., Schwarz U.I., McGrath J.S., et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clinical Pharmacology and Therapeutics 2007, 81(3):362-370.
30. Glaeser H., Mandery K., Sticht H., Fromm M.F., Konig J. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3. British Journal of Pharmacology 2010, 159(3):698-708.
31. Glavy J.S., Wu S.M., Wang P.J., Orr G.A., Wolkoff A.W. Down-regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of oatp1. The Journal of Biological Chemistry 2000, 275(2):1479-1484.
32. Godoy P., Hewitt N.J., Albrecht U., Andersen M.E., Ansari N., Bhattacharya S., et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 2013, 87(8):1315-1530.
33. Gong I.Y., Kim R.B. Impact of genetic variation in OATP transporters to drug disposition and response. Drug Metabolism and Pharmacokinetics 2013, 28(1):4-18.
34. Grube M., Kock K., Karner S., Reuther S., Ritter C.A., Jedlitschky G., et al. Modification of OATP2B1-mediated transport by steroid hormones. Molecular Pharmacology 2006, 70(5):1735-1741.
35. Gui C., Hagenbuch B. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. Biochemistry 2008, 47(35):9090-9097.
36. Gui C., Hagenbuch B. Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Science 2009, 18(11):2298-2306.
37. Gui C., Miao Y., Thompson L., Wahlgren B., Mock M., Stieger B., et al. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. European Journal of Pharmacology 2008, 584(1):57-65.
38. Guo G.L., Klaassen C.D. Protein kinase C suppresses rat organic anion transporting polypeptide 1- and 2-mediated uptake. The Journal of Pharmacology and Experimental Therapeutics 2001, 299(2):551-557.
39. Hagenbuch B., Gui C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008, 38(7-8):778-801.
40. Hagenbuch B., Meier P.J. The superfamily of organic anion transporting polypeptides. Biochimica et Biophysica Acta 2003, 1609(1):1-18.
41. Hagenbuch B., Scharschmidt B.F., Meier P.J. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. The Biochemical Journal 1996, 316(Pt. 3):901-904.
42. Hagenbuch B., Stieger B. The SLCO (former SLC21) superfamily of transporters. Molecular Aspects of Medicine 2013, 34(2-3):396-412.
43. Han S., Kim K., Thakkar N., Kim D., Lee W. Role of hypoxia inducible factor-1alpha in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer. Biochemical Pharmacology 2013, 86(6):816-823.
44. Hanggi E., Grundschober A.F., Leuthold S., Meier P.J., St-Pierre M.V. Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1. Molecular Pharmacology 2006, 70(3):806-817.
45. Hediger M.A., Coady M.J., Ikeda T.S., Wright E.M. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature 1987, 330(6146):379-381.
46. Hoekstra L.T., De Graaf W., Nibourg G.A.A., Heger M., Bennink R.J., Stieger B., et al. Physiological and biochemical basis of clinical liver function tests: A review. Annals of Surgery 2013, 257:27-36.
47. Huang J., Li N., Hong W., Zhan K., Yu X., Huang H., et al. Conserved tryptophan residues within putative transmembrane domain 6 affect transport function of organic anion transporting polypeptide 1B1. Molecular Pharmacology 2013, 84(4):521-527.
48. Huang S.M., Strong J.M., Zhang L., Reynolds K.S., Nallani S., Temple R., et al. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. Journal of Clinical Pharmacology 2008, 48(6):662-670.
49. Imai S., Kikuchi R., Kusuhara H., Sugiyama Y. DNA methylation and histone modification profiles of mouse organic anion transporting polypeptides. Drug Metabolism and Disposition 2013, 41(1):72-78.
50. Imai S., Kikuchi R., Kusuhara H., Yagi S., Shiota K., Sugiyama Y. Analysis of DNA methylation and histone modification profiles of liver-specific transporters. Molecular Pharmacology 2009, 75(3):568-576.
51. Imai S., Kikuchi R., Tsuruya Y., Naoi S., Nishida S., Kusuhara H., et al. Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines. Pharmaceutical Research 2013, 30(11):2880-2890.
52. Jacquemin E., Hagenbuch B., Stieger B., Wolkoff A.W., Meier P.J. Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(1):133-137.
53. Jung D., Elferink M.G., Stellaard F., Groothuis G.M. Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liver International 2007, 27(1):137-144.
54. Kalliokoski A., Niemi M. Impact of OATP transporters on pharmacokinetics. British Journal of Pharmacology 2009, 158(3):693-705.
55. Karlgren M., Vildhede A., Norinder U., Wisniewski J.R., Kimoto E., Lai Y., et al. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): Influence of protein expression on drug-drug interactions. Journal of Medicinal Chemistry 2012, 55(10):4740-4763.
56. Kato Y., Yoshida K., Watanabe C., Sai Y., Tsuji A. Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharmaceutical Research 2004, 21(10):1886-1894.
57. Khurana S., Venkataraman K., Hollingsworth A., Piche M., Tai T.C. Polyphenols: Benefits to the cardiovascular system in health and in aging. Nutrients 2013, 5(10):3779-3827.
58. Klaassen C.D., Aleksunes L.M. Xenobiotic, bile acid, and cholesterol transporters: Function and regulation. Pharmacological Reviews 2010, 62(1):1-96.
59. Kobayashi D., Nozawa T., Imai K., Nezu J., Tsuji A., Tamai I. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. The Journal of Pharmacology and Experimental Therapeutics 2003, 306:703-708.
60. Kock K., Koenen A., Giese B., Fraunholz M., May K., Siegmund W., et al. Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO2B1) function by protein kinase C-mediated internalization. The Journal of Biological Chemistry 2010, 285(15):11336-11347.
61. Kock K., Xie Y., Hawke R.L., Oberlies N.H., Brouwer K.L. Interaction of silymarin flavonolignans with organic anion-transporting polypeptides. Drug Metabolism and Disposition 2013, 41(5):958-965.
62. Konig J. Uptake transporters of the human OATP family. Molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. Handbook of Experimental Pharmacology 2011, 201:1-28.
63. Konig J., Muller F., Fromm M.F. Transporters and drug-drug interactions: Important determinants of drug disposition and effects. Pharmacological Reviews 2013, 65(3):944-966.
64. Kullak-Ublick G.A., Hagenbuch B., Stieger B., Schteingart C.D., Hofmann A.F., Wolkoff A.W., et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995, 109:1274-1282.
65. Kusuhara H., Sugiyama Y. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metabolism and Pharmacokinetics 2009, 24(1):37-52.
66. Letschert K., Faulstich H., Keller D., Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicological Sciences 2006, 91(1):140-149.
67. Leuthold S., Hagenbuch B., Mohebbi N., Wagner C.A., Meier P.J., Stieger B. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. American Journal of Physiology. Cell Physiology 2009, 296(3):C570-C582.
68. Li N., Hong W., Huang H., Lu H., Lin G., Hong M. Identification of amino acids essential for estrone-3-sulfate transport within transmembrane domain 2 of organic anion transporting polypeptide 1B1. PLoS One 2012, 7(5):e36647.
69. Li L., Lee T.K., Meier P.J., Ballatori N. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. The Journal of Biological Chemistry 1998, 273(26):16184-16191.
70. Li L., Meier P.J., Ballatori N. Oatp2 mediates bidirectional organic solute transport: A role for intracellular glutathione. Molecular Pharmacology 2000, 58(2):335-340.
71. Liu X., Huang J., Sun Y., Zhan K., Zhang Z., Hong M. Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2. Drug Metabolism and Disposition 2013, 41(3):602-607.
72. Liu T., Li Q. Organic anion-transporting polypeptides: A novel approach for cancer therapy. Journal of Drug Targeting 2014, 22(1):14-22.
73. Lotspeich W.D. Kidney, water and electrolyte metabolism. Annual Review of Physiology 1958, 20:339-376.
74. Mahagita C., Grassl S.M., Piyachaturawat P., Ballatori N. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. American Journal of Physiology. Gastrointestinal and Liver Physiology 2007, 293(1):G271-G278.
75. Mairinger S., Erker T., Muller M., Langer O. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo. Current Drug Metabolism 2011, 12(8):774-792.
76. Mandery K., Balk B., Bujok K., Schmidt I., Fromm M.F., Glaeser H. Inhibition of hepatic uptake transporters by flavonoids. European Journal of Pharmaceutical Sciences 2012, 46(1-2):79-85.
77. Mandery K., Bujok K., Schmidt I., Keiser M., Siegmund W., Balk B., et al. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochemical Pharmacology 2010, 80(11):1746-1753.
78. Mandery K., Sticht H., Bujok K., Schmidt I., Fahrmayr C., Balk B., et al. Functional and structural relevance of conserved positively charged lysine residues in organic anion transporting polypeptide 1B3. Molecular Pharmacology 2011, 80(3):400-406.
79. Marin J.J., Mangas D., Martinez-Diez M.C., El-Mir M.Y., Briz O., Serrano M.A. Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH. Biochimica et Biophysica Acta 2003, 1611(1-2):249-257.
80. Martinez-Becerra P., Briz O., Romero M.R., Macias R.I., Perez M.J., Sancho-Mateo C., et al. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3. Molecular Pharmacology 2011, 79(3):596-607.
81. Meier-Abt F., Mokrab Y., Mizuguchi K. Organic anion transporting polypeptides of the OATP/SLCO superfamily: Identification of new members in nonmammalian species, comparative modeling and a potential transport mode. The Journal of Membrane Biology 2005, 208(3):213-227.
82. Mengs U., Pohl R.T., Mitchell T. Legalon(R) SIL: The antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. Current Pharmaceutical Biotechnology 2012, 13(10):1964-1970.
83. Meyer zu Schwabedissen H.E., Bottcher K., Chaudhry A., Kroemer H.K., Schuetz E.G., Kim R.B. Liver X receptor alpha and farnesoid X receptor are major transcriptional regulators of OATP1B1. Hepatology 2010, 52(5):1797-1807.
84. Meyer zu Schwabedissen H.E., Kim R.B. Hepatic OATP1B transporters and nuclear receptors PXR and CAR: Interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Molecular Pharmaceutics 2009, 6(6):1644-1661.
85. Milne J.L., Borgnia M.J., Bartesaghi A., Tran E.E., Earl L.A., Schauder D.M., et al. Cryo-electron microscopy-A primer for the non-microscopist. The FEBS Journal 2013, 280(1):28-45.
86. Min A.D., Johansen K.L., Campbell C.G., Wolkoff A.W. Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter. The Journal of Clinical Investigation 1991, 87(5):1496-1502.
87. Mittur A., Wolkoff A.W., Kaplowitz N. The thiol sensitivity of glutathione transport in sidedness-sorted basolateral liver plasma membrane and in Oatp1-expressing HeLa cell membrane. Molecular Pharmacology 2002, 61(2):425-435.
88. Miyagawa M., Maeda K., Aoyama A., Sugiyama Y. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide. The Journal of Pharmacology and Experimental Therapeutics 2009, 329(2):551-557.
89. Moore R.J., Jackson K.G., Minihane A.M. Green tea (Camellia sinensis) catechins and vascular function. The British Journal of Nutrition 2009, 102(12):1790-1802.
90. Mukerjee P., Ostrow J.D. Review: Bilirubin pKa studies: New models and theories indicate high pKa values in water, dimethylformamide and DMSO. BMC Biochemistry 2010, 11:16.
91. Nakanishi T., Tamai I. Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs. Drug Metabolism and Pharmacokinetics 2012, 27(1):106-121.
92. Niemi M. Transporter pharmacogenetics and statin toxicity. Clinical Pharmacology and Therapeutics 2010, 87(1):130-133.
93. Niemi M., Pasanen M.K., Neuvonen P.J. Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacological Reviews 2011, 63:157-181.
94. Noe B., Hagenbuch B., Stieger B., Meier P.J. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(19):10346-10350.
95. Noe J., Portmann R., Brun M.E., Funk C. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metabolism and Disposition 2007, 35(8):1308-1314.
96. Nozawa T., Imai K., Nezu J., Tsuji A., Tamai I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. The Journal of Pharmacology and Experimental Therapeutics 2004, 308:438-445.
97. Obaidat A., Roth M., Hagenbuch B. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annual Review of Pharmacology and Toxicology 2012, 52:135-151.
98. Petzinger E., Joppen C., Frimmer M. Common properties of hepatocellular uptake of cholate, iodipamide and antamanide, as distinct from the uptake of bromosulfophthalein. Naunyn-Schmiedeberg's Archives of Pharmacology 1983, 322(2):174-179.
99. Pizzagalli F., Varga Z., Huber R.D., Folkers G., Meier P.J., St-Pierre M.V. Identification of steroid sulfate transport processes in the human mammary gland. The Journal of Clinical Endocrinology and Metabolism 2003, 88(8):3902-3912.
100. Ramachandran A., Betts G., Bhana S., Helme G., Blick C., Moller-Levet C., et al. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. European Journal of Cancer 2013, 49(7):1741-1751.
101. Roth M., Obaidat A., Hagenbuch B. OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. British Journal of Pharmacology 2012, 165:1260-1287.
102. Roth M., Timmermann B.N., Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metabolism and Disposition 2011, 39(5):920-926.
103. - exchange. The Journal of Biological Chemistry 1997, 272(42):26340-26345.
104. Scharschmidt B.F., Waggoner J.G., Berk P.D. Hepatic organic anion uptake in the rat. The Journal of Clinical Investigation 1975, 56(5):1280-1292.
105. Schodel J., Mole D.R., Ratcliffe P.J. Pan-genomic binding of hypoxia-inducible transcription factors. Biological Chemistry 2013, 394(4):507-517.
106. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacological Reviews 2002, 54(1):129-158.
107. Segawa M., Ogura J., Seki S., Itagaki S., Takahashi N., Kobayashi M., et al. Rapid stimulating effect of the antiarrhythmic agent amiodarone on absorption of organic anion compounds. Drug Metabolism and Pharmacokinetics 2013, 28(3):178-186.
108. Shirasaka Y., Kuraoka E., Spahn-Langguth H., Nakanishi T., Langguth P., Tamai I. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. The Journal of Pharmacology and Experimental Therapeutics 2010, 332(1):181-189.
109. Shirasaka Y., Mori T., Shichiri M., Nakanishi T., Tamai I. Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites. Drug Metabolism and Pharmacokinetics 2012, 27(3):360-364.
110. Shirasaka Y., Suzuki K., Shichiri M., Nakanishi T., Tamai I. Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. Drug Metabolism and Pharmacokinetics 2011, 26(2):171-179.
111. Shitara Y., Maeda K., Ikejiri K., Yoshida K., Horie T., Sugiyama Y. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: Their roles in hepatic clearance and intestinal absorption. Biopharmaceutics & Drug Disposition 2013, 34(1):45-78.
112. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochemical Pharmacology 2011, 82(12):1807-1821.
113. Sissung T.M., Reece K.M., Spencer S., Figg W.D. Contribution of the OATP1B subfamily to cancer biology and treatment. Clinical Pharmacology and Therapeutics 2012, 92(5):658-660.
114. Sreedharan S., Stephansson O., Schioth H.B., Fredriksson R. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. Gene 2011, 478(1-2):11-18.
115. Stieger B., Geier A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opinion on Drug Metabolism & Toxicology 2011, 7(4):411-425.
116. Stieger B., Heger M., de Graaf W., Paumgartner G., van Gulik T. The emerging role of transport systems in liver function tests. European Journal of Pharmacology 2012, 675(1-3):1-5.
117. Stieger B., Meier P.J. Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 2011, 12(5):611-631.
118. Sugiura T., Otake T., Shimizu T., Wakayama T., Silver D.L., Utsumi R., et al. PDZK1 regulates organic anion transporting polypeptide Oatp1a in mouse small intestine. Drug Metabolism and Pharmacokinetics 2010, 25(6):588-598.
119. Sugiura T., Shimizu T., Kijima A., Minakata S., Kato Y. PDZ adaptors: Their regulation of epithelial transporters and involvement in human diseases. Journal of Pharmaceutical Sciences 2011, 100(9):3620-3635.
120. Sugiyama D., Kusuhara H., Shitara Y., Abe T., Sugiyama Y. Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug Metabolism and Disposition 2002, 30(2):220-223.
121. Sugiyama Y., Yamashita S. Impact of microdosing clinical study-Why necessary and how useful?. Advanced Drug Delivery Reviews 2011, 63(7):494-502.
122. Sun A.Q., Ponamgi V.M., Boyer J.L., Suchy F.J. Membrane trafficking of the human organic anion-transporting polypeptide C (hOATPC). Pharmaceutical Research 2008, 25(2):463-474.
123. Svoboda M., Riha J., Wlcek K., Jaeger W., Thalhammer T. Organic anion transporting polypeptides (OATPs): Regulation of expression and function. Current Drug Metabolism 2011, 12(2):139-153.
124. Tamai I., Nozawa T., Koshida M., Nezu J., Sai Y., Tsuji A. Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharmaceutical Research 2001, 18:1262-1269.
125. Tell R., Wang Q.T., Blunier A., Benya R.V. Identification of ChIP-seq mapped targets of HP1beta due to bombesin/GRP receptor activation. Clinical Epigenetics 2011, 2(2):331-338.
126. Tweedie D., Polli J.W., Berglund E.G., Huang S.M., Zhang L., Poirier A., et al. Transporter studies in drug development: Experience to date and follow-up on decision trees from the International Transporter Consortium. Clinical Pharmacology and Therapeutics 2013, 94(1):113-125.
127. Van Beers B.E., Pastor C.M., Hussain H.K. Primovist, eovist: What to expect?. Journal of Hepatology 2012, 57(2):421-429.
128. van Montfoort J.E., Hagenbuch B., Groothuis G.M., Koepsell H., Meier P.J., Meijer D.K. Drug uptake systems in liver and kidney. Current Drug Metabolism 2003, 4(3):185-211.
129. Varma M.V., Rotter C.J., Chupka J., Whalen K.M., Duignan D.B., Feng B., et al. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. Molecular Pharmaceutics 2011, 8(4):1303-1313.
130. Vega-Hissi E.G., Estrada M.R., Lavecchia M.J., Pis Diez R. Computational chemical analysis of unconjugated bilirubin anions and insights into pKa values clarification. The Journal of Chemical Physics 2013, 138(3):035101.
131. Visentin M., Chang M.H., Romero M.F., Zhao R., Goldman I.D. Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1). Molecular Pharmacology 2012, 81(2):134-142.
132. Wang P., Hata S., Xiao Y., Murray J.W., Wolkoff A.W. Topological assessment of oatp1a1: A 12-transmembrane domain integral membrane protein with three N-linked carbohydrate chains. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 294(4):G1052-G1059.
133. Wang W.J., Murray J.W., Wolkoff A.W. Oatp1a1 requires PDZK1 to traffic to the plasma membrane by selective recruitment of microtubule-based motor proteins. Drug Metabolism and Disposition 2014, 42(1):62-69.
134. Wang P., Wang J.J., Xiao Y., Murray J.W., Novikoff P.M., Angeletti R.H., et al. Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface. The Journal of Biological Chemistry 2005, 280(34):30143-30149.
135. Wang X., Wolkoff A.W., Morris M.E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metabolism and Disposition 2005, 33(11):1666-1672.
136. Weaver Y.M., Hagenbuch B. Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates. The Journal of Membrane Biology 2010, 236(3):279-290.
137. Weil G., Frimmer M. Effect of silymarin on the isolated perfused rat liver poisoned by phalloidin. Arzneimittel-Forschung 1970, 20(6):862-863.
138. Wlcek K., Koller F., Ferenci P., Stieger B. Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metabolism and Disposition 2013, 41(8):1522-1528.
139. Xiao Y., Nieves E., Angeletti R.H., Orr G.A., Wolkoff A.W. Rat organic anion transporting protein 1A1 (Oatp1a1): Purification and phosphopeptide assignment. Biochemistry 2006, 45(10):3357-3369.
140. Yamaguchi H., Sugie M., Okada M., Mikkaichi T., Toyohara T., Abe T., et al. Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: Estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1. Drug Metabolism and Pharmacokinetics 2010, 25(3):314-317.
141. Yao J., Hong W., Huang J., Zhan K., Huang H., Hong M. N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1. PLoS One 2012, 7(12):e52563.
142. Zair Z.M., Eloranta J.J., Stieger B., Kullak-Ublick G.A. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics 2008, 9(5):597-624.
143. Zhang Y., Hays A., Noblett A., Thapa M., Hua D.H., Hagenbuch B. Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. Journal of Natural Products 2013, 76(3):368-373.
144. Zhang L., Huang S.M., Lesko L.J. Transporter-mediated drug-drug interactions. Clinical Pharmacology and Therapeutics 2011, 89(4):481-484.
145. Zhang L., Strong J.M., Qiu W., Lesko L.J., Huang S.M. Scientific perspectives on drug transporters and their role in drug interactions. Molecular Pharmaceutics 2006, 3(1):62-69.
146. Zhang L., Zhang Y.D., Strong J.M., Reynolds K.S., Huang S.M. A regulatory viewpoint on transporter-based drug interactions. Xenobiotica 2008, 38(7-8):709-724.
147. Zhou F., Lee A.C., Krafczyk K., Zhu L., Murray M. Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2. British Journal of Pharmacology 2011, 162(6):1380-1388.
148. Ziegler K., Frimmer M., Fasold H. Further characterization of membrane proteins involved in the transport of organic anions in hepatocytes. Comparison of two different affinity labels: 4,4'-Diisothiocyano-1,2-diphenylethane-2,2'-disulfonic acid and brominated taurodehydrocholic acid. Biochimica et Biophysica Acta 1984, 769(1):117-129.
149. Zolk O., Schnepf R., Muschler M., Fromm M.F., Wendler O., Traxdorf M., et al. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms. The American Journal of Pathology 2013, 182(1):234-243.